Our company - Contributing with pride and passion, beyond expectations

Tools content (print, share, increase/decrease text size):


Our websites


Middle area:

Scientific excellence in the field of health


November 5, 2013


For the second consecutive year, Sanofi and Institut Pasteur recognized four researchers for their innovative research in Life Sciences. The Sanofi Institut Pasteur awards were created to promote scientific excellence that contributes to advances in health.


Professor Peter C. Agre, 2003 Nobel Prize in Chemistry and chairman of the selection jury, Christopher A. Viehbacher, Chief Executive Officer, Sanofi and Professor Christian Bréchot, President of the Institut Pasteur were on hand for the awards ceremony at Sanofi headquarters in Paris.


The coming together of Sanofi and Institut Pasteur for these Awards reflects two of the core elements required in improving global health - innovation and partnership. Sanofi is proud to support this initiative.

Christopher A. Viehbacher, Chief Executive Officer

Outstanding work of four international researchers highlighted

Selected from among 80 scientists nominated, the winners were honored for their outstanding work in four major research areas:


Dr. Carolina Barillas-Mury, PhD, Senior Investigator at the NIH National Institute of Allergy and Infectious Diseases, USA, was rewarded in the field of “tropical and neglected diseases”.


Dr. Christelle Desnues, PhD, works for the CNRS Unit of Emerging Tropical Diseases at the La Timone University hospital, Marseille, France. She was nominated in the category of “Innovative Approaches to disease prevention, including vaccines”.


Pr. Roy Kishony, PhD, Harvard Medical School, USA, and Technion University, Haïfa, Israel, was nominated in the category of “New approaches to drug resistance”.


Pr. Alain Fischer, MD, PhD, Director of the Pediatric Immunology Unit (Inserm), Hôpital Necker-Enfants Malades, Professor at the Paris Descartes University, Paris France, was nominated in the “Immunology, immunomodulation, immunogenetics and translational technologies” category.


© Sanofi 2004-2014 - All rights reserved - Update: January 16, 2014